Effect of Lipid Based Eye Drops on Tear Film Lipid Layer Thickness
NCT03399292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2025-05-23
Summary
Dry eye disease (DED) is a common ocular disease, especially in the elderly population. Despite many treatment approaches, instillation of topical lubricants remains the mainstay of therapy. However, most of the topical lubricants available are not very well characterised and data about efficacy is sparse.
The aim of the present pilot study is to investigate the effect of topically administered lipid based eye drops on tear film lipid layer thickness in subjects with dry eye disease, Meibomian gland dysfunction, blepharospasm and healthy subjects.
Tear film lipid layer and tear film thickness will be assessed using the Lipiview II interferometer and OCT. Measurements will be performed before instillation of the eye drops and every 10 minutes after instillation for one hour. One eye will receive lipid based eye drops, the other eye will receive no eye drops and will be used as control. The study eye will be chosen randomly. In addition, Dynamic Meibomian gland imaging, Schirmer I test, corneal fluorescein staining and determination of tear break up time (BUT) will be performed
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
Cationorm MD sine eye drops
studyparticipants receive lipidbased eye drops once only in the study eye
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-12
- Primary Completion
- 2024-11-26
- Completion
- 2024-11-26
Countries
- Austria
Study Locations
More Related Trials
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
NCT01753596 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction
NCT03162497 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
NCT00848068 ·Status: COMPLETED ·Phase: NA
-
Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome
NCT03161080 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome
NCT02585453 ·Status: COMPLETED ·Phase: PHASE4
-
Lipids of the Human Tear Film and Their Effect on Tear Stability
NCT00803452 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating Abnormal Lipid Layer Thickness in Blepharoplasty Patients
NCT01787942 ·Status: COMPLETED ·Phase: NA
-
Changes in Tear Lipid Layer Thickness After Short Exposure to Light Emitting Diode Displays
NCT05003128 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516 ·Status: COMPLETED ·Phase: NA
-
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
NCT07245836 ·Status: TERMINATED ·Phase: PHASE4
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome
NCT01864330 ·Status: COMPLETED ·Phase: PHASE4
-
PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities
NCT05823961 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MAF-1217 in Patients With DED
NCT03833882 ·Status: COMPLETED ·Phase: NA
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Dry Eye With Supplements
NCT01364311 ·Status: WITHDRAWN ·Phase: NA
-
A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
NCT00355459 ·Status: WITHDRAWN ·Phase: NA
-
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease
NCT07007702 ·Status: COMPLETED
-
Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers
NCT01015209 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D)
NCT01165164 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4